Atlanthera
PrivateLast Round
VC Round
Jan 19, 2017
Total Funding Raised
$1.1M
Company Overview
Atlanthera is a biotechnology company that develops innovative drug delivery solutions for the treatment of bone diseases and bone cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlanthera Comparables
Compare Atlanthera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioVinc | 88% | |
| Taithera, Inc. | 85% | |
| Mesentech Inc. | 83% | |
Atlanthera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 19, 2017 | ||||
| Seed | Apr 1, 2014 |
Atlanthera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fair West | Seed, VC Round |
| GO Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2014
$1.1M round led by GO Capital and Fair West.
Atlanthera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Atlanthera's valuation, stock price, and market status.